chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client was given a booster dose of Pfizer BioNTech vaccine prior to age 16. Unknown side effects/symptoms at this time.
Strong pain; Burning in legs, arms and different part of the body; Pins and needles in different parts and electric shock sensation; Pins and needles in different parts and electric shock sensation; Neck lymph nodes inflammation; Body temperature swings from cold to hot and the other way around; This is a spontaneous report from a contactable consumer (patient, reported for herself). A 58-year-old female patient (who was not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EW0171 expiry date: unknown) dose 2 via an unspecified route of administration in left arm on 29Apr2021 01:15 PM (at the age of 58-years-old), as single for Covid-19 immunization. The patient did not have any medical history. She had known allergies: hives with yellow fever vaccine 7 years prior to this re-port. Concomitant medication in two weeks included EMERGEN-C (MINERALS NOS, QUERCETIN, THIOCTIC ACID, VITAMINS NOS). The patient received first dose of BNT162B2 (solution for injection, lot number: EW0151 expiry date: unknown) via an unspecified route of administration in left arm on 08Apr2021 01:15 PM (at the age of 58-years-old), as single for Covid-19 immunization. She did not receive any other vaccine same date of suspect product or within four weeks. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. On 05May2021 09:00 AM, She experienced extremely strong pain and burning in legs, arms and different part of the body, pins and needles in different parts and electric shock sensation, neck lymph nodes inflammation, body temperature swings from cold to hot and the other way around. This was the second day, and she did not have relief yet. It was stated that Tylenol 500mg and Ibuprofen 200mg did not relief absolutely anything. On an unknown date, the patient was hospitalized. The patient did not receive any treatment for other events. The patient underwent lab tests and procedures included Body temperature:  swings from cold to hot on 05May2021. The outcome of all events was not recovered.
Prior to the vaccine patient was active, Driving car, tutoring kids math as volunteer.  Started with sever upper back pain between shoulder blades. Used diclofenac gel, Advil ones a day - pain went away in this area within two weeks.  Debilitating pain transferred to lower back pain  and it continues for over two month. Tried to apply heat, any possible over the counter remedies for lower back pain such as lidocaine patches, Bungay    cream, heat patches. Tired physical therapy. Got cortisone and Novocain shut in facet joins in lumbar area. Still conditions did not improve. Now patient has to walk with walker, lost 20 pounds and in the addition patient has swollen legs.
Pt reported have itching begin within in 1-2 hours after vaccine on 2/5/19. Notified the health department on 2/8/19 when itching did not subside. Pt reported no rash, hives, or SOB. This RN consult with Medical Director, and he advised to have pt take OTC BENADRYL. If no Sx relief, pt should contact Private MD. Pt verbalized understanding. On 2/11/19 pt called this RN and stated the itching did not stop after taking the BENADRYL and she went to see her MD. He prescribed a steroid cream, prednisone, and increased strength BENADRYL. Called patient 2/12/19 and pt reports that symptoms are still present but somewhat improved. Notified MD and instructed this RN to complete VAERS.
Within one minute of administering vaccine, Pt became light headed and sweaty. She was made to lie down and her feet elevated for 15 mins. She was given fruit juice to drink. Discomfort lasted about 5 mins.
I had sore throat, tired, nausea, vomiting, headache, and loss of my appetite. I did have a dry cough and body aches.  These lasted for about 2 weeks. On Jan 12th, I tested positive for Covid-19.
REDNESS, INFLAMATION, ERYTHEMA, PRURITIS AT INJECTION SITE
shingles; Information has been received from a lawyer, regarding a case in litigation, and refers to a patient (pt) of unknown age and gender. No information about the pt's medical history, concurrent conditions and concomitant medications was provided. On or about 18-NOV-2013, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) as prescribed and/or administered by a pharmacist at a pharmacy for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date, subsequent to inoculation with zoster vaccine live (ZOSTAVAX), the pt was treated by a healthcare provider at a primary care unit for shingles. As a direct and proximate result of the pt's use of zoster vaccine live (ZOSTAVAX), the pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the event was considered to be not recovered. The reporter considered the event of shingles to be related to zoster vaccine live (ZOSTAVAX).
She is having back and spine pain; She is having back and spine pain; Bone pain/feels like her bone hurts; And that it is worse today than yesterday; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 19 year-old female patient received bnt162b2 (BNT162B2), administration date Aug2021 (Batch/Lot number: unknown) at the age of 19 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "back sprain" (unspecified if ongoing), notes: she sprained her back, like she did 2 years ago when she was tubing behind a boat. . The patient's concomitant medications were not reported. The following information was reported: BACK PAIN (non-serious), SPINAL PAIN (non-serious) all with onset Aug2021, outcome "unknown" and all described as "She is having back and spine pain"; BONE PAIN (non-serious) with onset Aug2021, outcome "unknown", described as "Bone pain/feels like her bone hurts"; CONDITION AGGRAVATED (non-serious) with onset Aug2021, outcome "not recovered", described as "And that it is worse today than yesterday". Therapeutic measures were taken as a result of back pain, spinal pain.  Additional information: Reporter was calling about an effect her daughter was having. age 19 years. Asked if anyone has reported bone pain.  She was having back and spine pain, but feels like her bone hurts.  Declined filing safety report.  Stated to agent that she was contact HCP at some point.  Daughter stated that it feels like she sprained her back, like she did 2 years ago when she was tubing behind a boat. Caller was giving her ibuprofen and using heating pads. Stated she was in tears today, and that it is worse today than yesterday, and she has a high pain tolerance, and is not a "cry baby". Caller stated her daughter took her first vaccine on Monday. Caller stated her daughter is experiencing major back and spine pain. Caller stated her daughter used Ibuprofen, ice, and heating pads today, and they did not help very much. Caller stated that it feels like her daughter's bones hurt, like a back sprain. Caller stated she has the vaccine information sheet, and that side effect is not listed.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
arm hurt after the first dose / arm felt better after exercising; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows:  The patient reported the case for himself/herself. The age at vaccination was not reported. The patient's arm hurt after the first dose of Shingrix but he/she went to the gym and exercised anyway.  Then arm felt better after exercising.  The patient enquired if it was ok to exercise 4 hours after Shingrix shot or he/she should have waited until the next day. Patient also questioned if exercising had effect his/her shot.
Redness, swelling, and warmth at FLUZONE site injection 2 days after injection.
This spontaneous case, initially received on 01-Jun-2017, was reported by other health professional (registered nurse) and concerns students in an academic campus, who received flu vaccine. This case deals with sixth report out of 23 reports. From 03-Oct-2016 to 04-Oct-2016, 176 students were vaccinated with FLUCELVAX in the total of 258 students in the campus. In the spring of 2017, an outbreak of the flu occurred and lasted for approximately 10 days. The reporter stated that, from 13-Apr-2017 to 18-Apr-2017, they treated 22 students with flu and among them 5 students had the vaccine on campus. In the beginning of 18-Apr-2017, they treated another 23 students with flu symptoms and only 3 of those had not received the flu vaccine. The students were tested positive for influenza A via rapid flu test with nasopharyngeal swab. This case concerns a 15-years-old patient of unspecified gender. On 03-Oct-2016, the patient received FLUCELVAX QIV (dose, route of administration and anatomical location: not reported, batch number: 185888, expiration date: 31-May-2017). On 19-Apr-2017, the patient was tested positive for influenza A via rapid flu test with nasopharyngeal swab (characterized as vaccination failure). Based on the investigation performed, it can be concluded that FLUCELVAX 185888 was manufactured in compliance with the approved internal procedures and in accordance with the quality requirements. No evidence was found that the LOE complaint was the result of the Fill Finish or Bulk manufacturing process and no trends were identified for the batch number 185888, or any other FLUCELVAX QIV batches from the 2016-2017 FLUCELVAX Commercial season. Therefore no internal root cause could be confirmed. Outcome of influenza A virus infection and vaccination failure was not reported. The reporter did not assess the seriousness and did not provide the causality between events and suspect vaccine. The reporter stated that, the students received flu vaccine had less severe symptoms than those who had not received the flu vaccine. Batch review report (QAIR number: 1022277) received from quality assurance department on 29-Jul-2017: QA investigation results were updated. Narrative amended accordingly. Non significant case correction received on 10-Aug-2017: The narrative was corrected.
Fever 104.8; swelling @ site of inject; pain in joints; hypotonic episodes;
Pain and tightness in center of chest, sensitive to touch/pressure.   Pain built over succeeding days, but varied in intensity over the course of individual days.  Diagnosed by civilian health care provider as potential inflammation of structures in breastbone area on 20 October.  Prescribed 500mg Naproxin 2/daily for six weeks as treatment.  As of 5 November, prescription alleviates discomfort but sense of pressure persists with dull pain appearing near time of next does.  This sense is gradually diminishing over time.  Provider cleared patient to receive second vaccine dose.
SHINGRIX Vial Kit (not listed in drop-down above) - Shivering, muscle ache, headache, tiredness, pain at injection site.
Patient given 0.3mL injection of Pfizer COVID-19 booster diluted with 0.8mL sodium chloride instead of the correct amount of 1.8mL diluent.
flu-like symptoms/ felt like he had the flu; arm is very inflamed (which is his initial concern) and hot to touch; redness tripled in size on Saturday on the injection site; His arm is not as hard around the injection site but still has a bit of feeling from the arm; arm was really inflamed; there was a patchy area an inch to an inch and a half circumference around the shot area; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 05Oct2021 (Lot number: FC3184) at the age of 58 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Crohn's disease" (ongoing), notes: diagnosed in the 90s. Concomitant medication(s) included: CIMZIA taken for crohn's disease (ongoing). Vaccination history included: Bnt162b2 (1st dose, LOT: EN6204, left arm, injection, unknown dosage), administration date: 11Mar2021, when the patient was 58 years old, for Covid-19 immunization; Bnt162b2 (2st dose,LOT: EP6955, left arm, unknown dosage, injection), administration date: 01Apr2021, when the patient was 58 years old, for Covid-19 immunization. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 06Oct2021, outcome "recovered" (07Oct2021), described as "flu-like symptoms/ felt like he had the flu"; FEELING HOT (non-serious) with onset 06Oct2021, outcome "unknown", described as "arm is very inflamed (which is his initial concern) and hot to touch"; VACCINATION SITE ERYTHEMA (non-serious) with onset 06Oct2021, outcome "unknown", described as "redness tripled in size on Saturday on the injection site"; LIMB DISCOMFORT (non-serious) with onset 06Oct2021, outcome "not recovered", described as "His arm is not as hard around the injection site but still has a bit of feeling from the arm"; INFLAMMATION (non-serious) with onset 06Oct2021, outcome "unknown", described as "arm was really inflamed"; RASH (non-serious) with onset 06Oct2021, outcome "not recovered", described as "there was a patchy area an inch to an inch and a half circumference around the shot area".  Additional Information: The patient did not received any other vaccination prior to Pfizer covid vaccine, Caller states he was going to get the flu shot too but then the pharmacist said that his recommendation was to wait, if he has a reaction to he won't know which one, so caller states he's going to wait a couple weeks until he gets his flu shot. Caller states he just wants to know if his arm is going to fall off.  No follow-up attempts are possible. No further information is expected.
2 rashes on tongue; sore arm; one hour after receiving it I got a minor headache; 6 hours after receiving it I felt nauseous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Aug2021 16:00 (Lot number: FC3181) at the age of 36 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.  The following information was reported: TONGUE ERUPTION (non-serious) with onset 13Aug2021 16:45, outcome "recovered" (Aug2021), described as "2 rashes on tongue"; HEADACHE (non-serious) with onset 13Aug2021, outcome "recovered" (Aug2021), described as "one hour after receiving it I got a minor headache"; NAUSEA (non-serious) with onset 13Aug2021, outcome "recovered" (Aug2021), described as "6 hours after receiving it I felt nauseous"; PAIN IN EXTREMITY (non-serious) with onset 13Aug2021 16:45, outcome "recovered" (Aug2021), described as "sore arm". Therapeutic measures were not taken as a result of tongue eruption, headache, nausea, pain in extremity.  Additional information: The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not received other medication within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient dose not have any known allergy.  No follow-up attempts are possible. No further information is expected.
Moderate pain in left shoulder  Joint pains Stiff neck Moderate fever (warm to the touch, did not take temp) Night sweats, chills ? alternating hot and cold throughout the night Treated with Aleve and Excedrine PM
This case was reported by a pharmacist and described the occurrence of bronchospasm in a patient who received ENGERIX B for prophylaxis. On an unknown date, the patient received ENGERIX B at an unknown dose. On an unknown date, unknown after receiving ENGERIX B, the patient experienced bronchospasm and reaction to drug excipient. On an unknown date, the outcome of the bronchospasm and reaction to drug excipient were unknown. The reporter considered the bronchospasm and reaction to drug excipient to be possibly related to ENGERIX B. Additional details were reported as follows: The age at vaccination was not reported. The reporter had a patient who had a bronchospasm reaction to ENGERIX-B possibly due to the yeast component. This patient wants to get the SHINGRIX vaccine at the time of reporting. As far as the patient could tell from the PPI's this should be fine but reporter just wanted to verify that there were no ingredient duplications between the two vaccines.
Numbness and tingling in face. It lasted until around 3pm on 3/2/2021.  It was like you had been given novacane at the dentist.  Onset was about 2 hours after the vaccination.  It was forehead through neck. By the  next morning  it was nose and nasal passages to chin.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 18-AUG-2017 the patient was vaccinated with a dose of RECOMBIVAX HB lot # L026598 that had expired on 26-JUN-2017, 0.5 ml, intramuscular for prophylaxis. No adverse event was reported.  Additional information has been requested.
Brain fogginess; Difficulty in breathing; Patient is very sleepy all the time; Has no energy at all; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fogginess), DYSPNOEA (Difficulty in breathing), SOMNOLENCE (Patient is very sleepy all the time), ASTHENIA (Has no energy at all) and FATIGUE (Tiredness) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A. and 032L20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer female (Breast Cancer left side) and Heparin-induced thrombosis (H/o Heparin Induced Thrombosis and was hospitalized before receiving the vaccination both the doses). Concurrent medical conditions included Thrombosis NOS (Patient developed clot in one kidney and half of the spleen was affected as well because of the clot) and Single functional kidney (Now patient presently surviving with one functioning kidney.). Concomitant products included LOSARTAN and SERTRALINE (SERTA [SERTRALINE]) for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Brain fogginess), DYSPNOEA (Difficulty in breathing), SOMNOLENCE (Patient is very sleepy all the time), ASTHENIA (Has no energy at all) and FATIGUE (Tiredness). At the time of the report, FEELING ABNORMAL (Brain fogginess), SOMNOLENCE (Patient is very sleepy all the time), ASTHENIA (Has no energy at all) and FATIGUE (Tiredness) had not resolved and DYSPNOEA (Difficulty in breathing) outcome was unknown.            The patient post receiving the second dose developed the symptoms of tiredness and still had the problem of brain fogginess and difficulty in breathing. The patient reported that the tiredness and the brain fogginess was still persisting following the 1st shot. At the time of report the patient was very sleepy all the time and had no energy at all.  The patient also reported that they would be visiting the Neurologist in July.  The patient didn't take any treatment for the side effects.   This case was linked to MOD-2021-042756 (Patient Link).
Patient was not given the vaccinations IM. She showed me her injection site, and it was approx 4-5 inches above her elbow on her left arm. Patient had an injection site reaction that included swelling, itching and redness. Her arm was still red and swolled today in the office.
On 09-OCT-00, the vaccinee received her first right deltoid dose of hepatitis B vaccine (brand unknown). On 10-OCT-00, she experienced a fever blister and a red neck. No treatment was given. As of 11-OCT-00, the outcome of the events is improving.
Myocardial Infarction suffered on July 15,2021 with no risk factors or family history.  Official diagnosis was a non stemi MI.  Cardiac cath revealed no coronary artery disease. Currently continue to be evaluated with tests and on heart medications.  Not sure if this is related or not but have had severe left neck pain which began about May/June.  I have taken sterorids for this pain and am currently in physical therapy.
Fainted approx. 5 min after receiving vaccination, was revived immediately and felt back to normal about 5 min after incident.
First Moderna dose was given at 6:40 PM on Nov 11, 2021. At 7:15 AM on Nov 14, 2021, patient experienced sharp stabbing chest pain,  unable to catch her breath, heart gripping tightly. This occurred while relaxing with a cup of coffee on the couch. Slowly able to breathe, patient went and took 3 ibuprofen (total 600 mg) at 7:15 AM on Nov 14. Some small relief was felt, sharp stabbing pain went away but tight gripping pressure or clenching feeling on the heart continued. 6 hours later at 1:00 PM, patient swallowed one coated aspirin whole, 325 mg. Within one hour, massive headache started by 2:00 pm. Decided to go to the ER because gripping heart pain continued and went up the left shoulder and up the neck from time to time. Went to ER. Tests noted in Item 19 below.
5JUL95 hospitalization w/dehydration, dec LOC, febrile, mom states pt actually became ill on 5JUL95 not a/;tx included rehydration, no obvious signs of disease found, MD believed above s/s were related to vax 26JUN95
dose of Kinrix that was administered 05Sep2023 from lot number H99J7, which had an expiration date of 26May2023; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received DTPa-IPV (Kinrix) (batch number H99J7, expiry date 26-MAY-2023) for prophylaxis.   On 05-SEP-2023, the patient received Kinrix. On 05-SEP-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: dose of Kinrix that was administered 05Sep2023 from lot number H99J7, which had an expiration date of 26May2023).  The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 6th Sep 2023 Physician Assistant reported he was consulted about a dose of Kinrix that was administered on 05Sep2023 which had an expiration date of 26May2023. At the time of reporting, the reporter did not had any patient information or further details. The reporter consented to follow up.  The Vaccine Administration Facility was the same as Primary Reporter. The patient received kinrix vaccine which was already expired which led to expired vaccine used.